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Relatively large amounts of  a glycoprotein, designated gp70 because of its molecular 
weight of 70,000 and its structural and immunologic similarity to retroviral envelope 
protein, circulate in the blood of many murine strains free from any association with 
viral particles (1-5). Although one finds multiple immunologically and structurally 
related  gp70  in  all  mice,  the  structure  of this  serum  gp70  molecule most  closely 
resembles, but is not identical by peptide fingerprint analysis, to the coat protein of 
xenotropic virus isolated only from NZB and NZB ×  NZW F1 hybrid (NZB ×  W) 
mice (5-7). 
The origin of serum gp70 and the mechanisms controlling its expression are still 
unclear. Although  lymphoid cells express virion-free gp70 on their surfaces  (8-10), 
these  cells  do  not  seem  to  be  a  major  source  for  serum  gp70,  because  neither 
thymectomy nor splenectomy affects serum levels of gpT0 (11). A tissue or organ that 
is directly or indirectly responsive to testosterone was suggested as the origin of serum 
gp70 (11); however, no serological or immunohistochemical evidence indicates either 
production or subsequent release of gp70 into the circulating blood by any organ or 
tissue. 
In recent experiments (12), a single injection of bacterial lipopolysaccharide (LPS) 1 
greatly enhanced the expression of serum gp70 in murine strains with high baseline 
levels of gp70 (>10 #g/ml) such as NZB, NZB ×  W, NZW, BXSB, DBA/2, 129(Gix+), 
but  not  in  those  with  lower  levels  (<5  #g/ml)  including  C57BL/6,  BALB/c,  or 
129(Gix-). This increased expression of serum gp70 was unrelated to the activation of 
endogenous xenotropic virus  or other  viral  genomes.  Therefore, this  experimental 
model seemed suitable for investigation of the cellular origin of serum gp70 and the 
control mechanism for its production. Our results indicate that serum gp70 behaves 
like an acute phase reactant (APR) and is synthesized mainly by hepatic cells, as are 
many other APR and serum proteins. 
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Materials and Methods 
LPS.  LPS purified from Escherichia coli 0Ill:B4 and a  lipid A component from LPS of 
Salmonella minnesota R595 were generously provided by Dr.  D.  C.  Morrison (Department of 
Microbiology, Emory  University School of Medicine, Atlanta, Ga.).  E.  coli 0111:B4  LPS 
extracted by the phenol-water method (13) was further fractionated by Sepharose 4B column 
chromatography,  and  fraction  II  of this preparation  was  used  (14). Native  protoplasmic 
polysaccharides (NPP)  (15), alkali-treated LPS  (16) (both lipid A free), as well as untreated 
LPS from E. coli 0113 were kindly provided by Dr. J. A. Rudbach (Department of Microbiology, 
University of Montana, Missoula, Mont.). All LPS and NPP preparations were diluted to the 
desired concentrations with sterile saline and injected intraperitoneally  in a final volume of 0.4 
ml. 
Mice.  All mice used in this study were 6-12 wk old.  NZB, NZB  ×  W, BXSB,  DBA/2, 
129(Gxx+), 129(Gix-), C57BL/6, and BALB/c mice were  obtained from the mouse breeding 
colony at Scripps Clinic and Research Foundation. Mice were bled from the retroorbital plexus, 
and the resulting sera were stored at -20°C until use. 
T Cell-depleted Mice and Radiation Chimeras.  T cell-depleted mice were prepared as follows: 2 
mo-old NZB ×  W  male mice were thymectomized, subjected to whole body exposure of 950 
tad  of lSTCs y-rays  (Gammacell 40,  Atomic Energy of Canada  Ltd.,  Ottawa,  Can.),  and 
reconstituted with 5 ×  10  e syngeneic bone marrow cells treated with anti-Thy-l.2 sera (New 
England Nuclear, Boston, Mass.)  and guinea pig complement (Pel-Freez Biologicals,  Rogers, 
Ariz.).  16 d after reconstitution, recipients were injected with 25/~g of LPS i.p. and tested for 
serum gp70 responses.  The effectiveness of T  cell depletion was demonstrated by the marked 
impairment of antibody responses to the T dependent antigen, human gamma globulin (HGG), 
in T  cell-depleted mice (24 "1-  14/~g/ml) compared with unmanipulated mice (480:1:35 btg/ 
ml), and by the responsiveness  of their spleen cells to 1/xg/ml of concanavalin A (stimulation 
index of T cell-depleted mice was 3.8 and of unmanipulated mice, 113.2). 
Radiation chimeras were made as follows: after 129(Gtx  +) and 129 (Gix-) mice received 900 
tad of irradiation, we  injected each substrain with 50  ×  l0  s spleen cells  from the congenic 
counterpart. 1 mo later, 25/.tg of LPS was administered i.p., after which the serum gp70 and 
IgM responses were monitored. 
Assay ofgp70.  Concentrations  of gp70 in sera and tissue extracts of test mice were determined 
by their capacity to inhibit the binding  of goat antibody to feline leukemia virus to 12SI-labeled 
gp70 from Rauscher murine leukemia virus (MuLV). The details of this radioimmunoassay 
were described previously (17). 
Assay of IgM and Anti-HGG.  A solid-phase radioimmunoassay was performed to assess the 
serum levels of IgM. The same assay,  but with human IgG used as the antigen, quantitated 
anti-HGG antibodies in sera  after  mice received an intravenous injection of 400  p.g  heat- 
aggregated HGG. These assays were performed as described (18, 19). 
Quantitation of Haptoglobin.  Concentrations of haptoglobin in murine serum were measured 
by radial immunodiffusion  in agar with goat anti-human haptoglobin antiserum (N. L. Cappel 
Laboratories, Cochranville, Pa.) used according to the method of Mancini et al. (20). Results 
are expressed  as a percentage of values from the pooled sera of 3-mo-old C57BL/6 male mice. 
Chemical Reagents.  Turpentine oil was obtained from American Scientific Products, Irvine, 
Calif. Polyriboinosinic-polyribocytidylic  acid (poly I-poly C), colchicine and o-galactosamine 
(D-GaIN) were purchased from Sigma Chemical Company, St.  Louis, Mo. and dissolved in 
pyrogen-free saline immediately before use. 
Preparation of Tissue Extracts.  Samples weighing 0.06-0.2  gr from livers,  kidneys, spleens, 
thymuses, and lungs of test  mice were  placed in tissue grinders and mixed with cold 0.01 M 
phosphate-buffered saline (PBS),  pH  7.2, to yield a  10% homogenate (wt/vol). These tissue 
homogenates in an  ice  bath were sonicated with a  Sonifier Cell  Disrupter  (Heat  Systems- 
Ultrasonics, Inc., Plainview, N.  Y.)  and then centrifuged at  2,000 g for  15 min at 4°C. The 
supematants were  treated with Triton X-100 (Rohm and Haas Co.,  Philadelphia, Pa.)  in a 
final concentration of 0.4% at 37°C for 15 min, followed by three cycles of freezing and thawing 
and centrifugation at  2,000 g  for  15  rain at  4°C. The final supernatants were  used for  the 
quantitation of tissue gp70. 
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by using  131I-labeled bovine  serum  albumin  (BSA; Calbiochem-Behring  Corp.,  American 
Hoechst Corp., San Diego, Calif.) as a volume marker according to the modified procedure of 
Mathison  and Ulevitch  (21). Briefly, 0.2-0.3 mg of I~II-BSA  with a specific activity of 1.5-2.5 
#Ci/#g was injected intravenously  into NZB ×  W female mice, whose sera were collected 3 h 
later.  The radioactivity  of sera with  approximately 15-20 #Ci/ml was >90% precipitable  in. 
10% trichloroacetic  acid. 50-100-#1 samples containing 1 ×  I06-2 ×  10  s cpm of t81I-BSA were 
then injected intravenously  into 2-too-old NZB × W female mice 5 rain before killing. On the 
basis of counts per minute per ml of tissue extract  and per ml of blood, the blood content in 
various tissue extracts was calculated.  From the measurement  of gp70 content in tissue extracts 
and in blood, the amounts of gp70 present in tissue were computed. 
Fluorescence Microscopy  for Detection ofgp70 in Livers.  To localize gp70 in livers of test mice, 
each liver was perfused with 0.05 M PBS, pH 7.2, and with the periodatedysine-paraformal- 
dehyde (PLP) solution as described by McLean and Nakane (22). Then, 2-4 mm liver fragments 
were fixed with PLP for 3 h at 4°C and washed, first with  7% sucrose in PBS, then with  15% 
sucrose in PBS, and finally with PBS containing 25% sucrose and 20% glycerol. The fixed liver 
samples were embedded in AmesOCT compound, quick frozen, and sectioned into 4-#m slices 
on a cryostat  at -35°C. To demonstrate gpT0 in this tissue, sections were incubated with the 
IgG fraction of goat anti-Rauscher MuLV gp70 (the gift of Dr. J. H. Elder, Scripps Clinic and 
Research Foundation)  or normal goat IgG for 30 rain at room temperature.  After being washed, 
fluorescein isothiocyanate-conjugated  rabbit  anti-goat  IgG (N.  L. Cappel Laboratories)  was 
applied  for 30 rain  at  room temperature.  The specificity of fluorescence was controlled  by 
absorbing  the goat anti-Rauscher MuLV gp70 with Rauscher MuLV. For this purpose, anti- 
gp70 IgG (0.5 ml ofa 6 mg/ml solution) was incubated with 3 mg Rauscher MuLV for 30 rain 
at 37°C, followed by centrifugation  at  100,000 g for 60 rnin at 4°C. The resulting supernatant 
was used as absorbed antibodies. 
Results 
Induction of High Serum Levels of gp70 in Mice by LPS.  In 2-mo-old NZB female mice 
whose baseline levels of serum gp70 were 46:1:12 #g/ml, the injection of 25 #g i.p. of 
LPS from E. coli 0111 :B4 caused an increase of gp70 to 376 :t: 73 #g/ml within 24 h. 
This gp70 response was dose related  (Fig.  1).  Serum gp70 concentrations increased 
significantly after  injection of 25  ng of LPS  (137  +  27 #g/ml)  and  reached  near- 
maximal responses with 25 #g of LPS in NZB mice.  Results were similar in strains 
with high baseline levels of serum gp70 (>10 #g/ml) such as NZB X W, BXSB, DBA/ 
2,  and  129(Glx  +)  mice.  However, murine strains  with  low serum  gp70  (<5 #g/ml) 
such as C57BL/6 or BALB/c mice showed no increase in serum gp70 at any dose of 
LPS, as described previously (12). 
To  define  that  portion  of the  LPS  molecule  responsible  for  stimulating  gp70 
response, the lipid A  fraction extracted from S. minnesota R595 LPS and lipid A-free 
preparations ofF_., coli 0113 LPS, such as NPP and alkali-treated LPS, were tested for 
gp70-producing capacity in NZB x  W mice. The injection of purified lipid A induced 
serum  levels  of gp70 about  equal  to those stimulated  by the  entire  LPS molecule 
(Table I). In contrast, NPP and alkali-treated LPS preparations, both of which lack 
the lipid A component, induced only minimal activity. 
Unrelatedness of Serum gp 70 Induction by LPS and Activation of Lymphocytes.  Our previous 
studies (I 2) demonstrated that the increase in serum gp70 after injection of LPS is not 
associated with activation of endogenous virus nor attributable to the cellular death 
caused by LPS, but results from active synthesis of gp70. Because thymocytes express 
retroviral gp70 on their surfaces (8-10), we now examined the possible participation 
of T  cells  in  the  serum  gp70  response  stimulated  by  LPS.  After T  cell-depleted 
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Fro.  1.  Serum  gp70 responses of 2-mo-old NZB female mice injected with various doses of LPS 
from E. coh" O111 :B4. Each point represents a mean value from five mice. 
TABLE  I 
Effect of Various Preparations of LPS on Serum gp 70 Responses 
LPS preparations* 
Serum gp70 
Day 0  Day 1 
#g/ml 
LPS  47.3 ±  12.9:[:  280.7 ± 41.3 
NPP  50.1 ± 3.8  85.5 ±  17.6 
Alkali-treated LPS  51.5 ±  10.2  94.5 ± 39.6 
Lipid A  44.7 :l: 3.l  312.5 + 99.8 
Saline  48.2 ±  14.5  52.2 ± 6.7 
* 50 #g of each LPS preparation was injected i.p. on day 0 into 2-mo-old 
NZB X W male mice. LPS, NPP, and alkali-treated LPS were purified from 
E. coli 0113 and lipid A from S. minnesota R595. Note that  both NPP and 
alkali-treated LPS lacked lipid A. 
:~ Mean ±  1 SD for five mice. 
ment-treated syngeneic bone marrow cells) received 25 #g LPS i.p., their serum gp70 
responses were compared with those of unmanipulated  NZB ×  W  mice. LPS increased 
serum gp70 levels from 61  +  22 #g/ml to 336 ±  82 #g/rnl in T  cell-depleted mice. 
This increased response was  only slightly lower than that  in controls with  normal 
numbers ofT  cells (from 62 +  11 #g/ml to 590 ±  69 #g/ml), thus excluding a  major 
role of T  cells in serum gp70 responses induced by LPS. 
LPS is a potent B cell activator (23), and the activation of B cells might account for 
the enhanced expression of gp70 on their surfaces (24, 25). Therefore, we examined 
the possible relationship between synthesis of serum gp70 promoted by LPS and the 
activation of B cells, measured as serum levels of polyclonal IgM antibodies. For this HARA, IZUI,  AND DIXON  349 
purpose, 2-mo-old NZB ×  W  mice were lethally irradiated (1,000 rad), and 2 d  later, 
were injected with 25 #g of LPS.  1 d  after injection of LPS, concentrations of serum 
gp70 were ~ 10 times as high as those before injection of LPS regardless of irradiation 
(Table II).  However,  5  d  after  the  injection of LPS,  serum  IgM  levels doubled in 
unirradiated mice, but actually dropped in irradiated mice. Radiation alone had no 
significant effect on serum levels of gp70, but again somewhat decreased the concen- 
trations of serum IgM. 
To confirm that the activation of lymphocytes was unrelated to the LPS-induced 
serum gp70 response, this response was examined in radiation chimeras of 129(Gix  +) 
and  129(Gxx-) congenic mice. It had been shown that LPS enhances the expression 
of serum gp70 in the former high gp70 mice but not in the latter (12), which have 
much lower concentrations of gp70 in sera and on the surface of lymphocytes (2,  10, 
12). Baseline levels of serum gp70 in irradiated 129(GLX  +) or 129(Gix-) mice reconsti- 
tuted with reciprocal spleen cells were comparable to those of untreated 129(Gtx  ÷) or 
129(Cnx-) mice, regardless of the donor's cell type (Table III). Unmanipulated Gxx  + 
mice and Cnx  ÷ mice given Gix- spleen cells responded equally well to the injection of 
25 #g of LPS, developing high serum levels of gp70. However, little increase in serum 
TABLE II 
Serum gp 70 and IgM Responses to LPS in Lethally Irradiated NZB  ×  W Mice 
Treatment  Injection 
gp70  IgM 
Day 0  Day 1  Day 0  Day 5 
#g/ml  #g/ml 
Radiation*  LPS:~  46.2 ± 5.2§  476.1  ± 65.6  627 ±  104  443 ±  168 
None  LPS  54.2 ± 4.3  561.3  ± 53.9  530 ±  103  1,158  ±  118 
Radiation  Saline  47.1 ±  15.8  46.1 ± 3.2  632 ± 75  442 ± 35 
None  Saline  48.4 ± 5.2  54.1 ± 7.6  664 ± 28  586 ± 61 
* 2-mo-old NZB × W male mice were irradiated with 1,000 rad 2 d before injection of LPS 
from E. coli 0111:B4. 
25 #g LPS was injected i.p. on day 0. 
§ Mean ±  1 SD for six mice. 
TABLE  III 
Failure of Gtx- Mice Reconstituted with G1x  + Spleen Cells to Produce Serum gp 70 after 
Injection of LPS 
Mice* 
Serum gp70:~  Serum IgM:~ 
Day 0  Day 1  Day 0  Day 5 
#g/ml  ~g/ml 
I. Gix  + given  Gix- cells  7.0 ± 0.9§  65.6  ±  13.5  253 ± 77  946 +  196 
II. G~x  +  8.3 ±  1.3  58.4 ±  15.4  180 ± 42  808 ± 245 
III. Gix- given  Gix  + cells  1.1 ± 0.3  2.2 ±  1.1  200 ± 36  1,035 ± 252 
IV. Gtx-  0.3 ± 0.2  1.1 ± 0.8  173 ±  15  1,038 ±  109 
* I. Gxx  ÷ mice reconstituted with Gix- spleen cells. 
II. Unmanipulated Gm+ mice. 
III.  Gix- mice reconstituted with Gtx- mice. 
IV. Unmanipulated Gtx- mice. 
Serum levels  of gp70 and IgM were determined 1 and 5 d, respectively,  after injection of 
25 #g of LPS from E. coh" 0111 :B4. 
§ Mean ±  1 SD for 5-10 mice. 350  SERUM  gp70  AS  AN  ACUTE  PHASE  REACTANT 
gp70 was seen in  129(Gzx-) recipients reconstituted with Gix  + spleen ceils or unma- 
nipulated 129(Cnx-) mice. It should be noted that a higher frequency of gp70-positive 
cells in the spleens of Gin- mice reconstituted with Gtx  + cells than in GIx  + mice given 
Gix- cells revealed that spleen cells of both chimeras were of donor type. Further, sera 
of both groups of mice developed comparable amounts of polyclonal IgM antibodies 
as a result of B cell activation by LPS (Table III). 
Serum gp70 as  an  APR.  Because  LPS  is  a  potent  inducer of APR  (26-28),  the 
kinetics of serum gp70 responses were compared with those of the APR, haptoglobin, 
in LPS-injected NZB ×  W  female mice. Serum levels of both gp70 and haptoglobin 
increased as early as 6 h after the injection and peaked at ~24 h, although gp70 levels 
returned to the preinjection levels more rapidly than those of haptoglobin (Fig. 2). At 
their peaks,  gp70 and  haptoglobin levels were -t0  times higher than  those before 
injection of LPS. 
The possible stimulation of serum gp70 synthesis by various inducers of APR was 
also investigated. NZB ×  W  male mice were injected intraperitoneally with 0.01  or 
0.05 ml of turpentine oil or 100, 200, or 500 #g ofpoly I-poly C. 1 d after the injection, 
dose-dependent  increases of serum  gp70  and  of haptoglobin  were observed in  the 
animals injected with turpentine oil or poly I-poly C (Table IV). 0.05 ml of turpentine 
oil and  500 #g of poly I-poly C  induced the production of haptoglobin and serum 
gp70 as effectively as 25 #g of LPS. This finding was confirmed in DBA/2 and BXSB 
mice, which are natively high in serum gp70 concentrations (data not shown). Table 
IV also shows that although LPS stimulated the production of serum IgM as a result 
of B cell activation, neither turpentine oil nor poly I-poly C elevated the serum levels 
of IgM, ruling out possible contamination by LPS in preparations of turpentine oil 
and poly I-poly C. 
Tissue Origin of Serum gp70 Induced by LPS.  Because, in the foregoing experiments, 
the induction of serum gp70 by LPS was apparently unrelated to the activation of 
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Fro.  2.  Serum gp70 and haptoglobin responses of 2-mo-old NZB x  W female mice to injection of 
25 p.g of LP8  from E.  coh" 0111:B4.  Each point represents mean  from five mice.  Vertical bars 
represent the limits of 1 SD. O, gp70 (LPS); Q, gp70 (control); A  haptoglobin (LPS), A, haptoglobin 
(control). HARA, IZUI, AND DIXON 
TABL~  IV 
Serum gp 70, Haptoglobin, and lgM Responses after Injection of 
lnducers of APR 
Inducers*  gp70¢  Haptoglo-  bin:~  IgM:~ 
ttg/ml  %  #g/ml 
LPS 25 #g  590 ± 69§  421 ±  52  1,640 ±  305 
Turpentine oil 0.01 ml  172 ±  34  503 ±  137  644 ± 87 
0.05 ml  413 ±  38  533 +  183  523 ±  52 
351 
Poly I-poly C  100 #g  322 ± 84  257 ± 46  456 ±  133 
200 #g  426 :t: 58  307:1:63  507 ±  86 
500/.tg  543 ±  122  438 ±  29  502 ±  162 
Saline  63 -I- 6  119 :t: 32  604 -1- 101 
* Inducers of APR were injected i.p. on day 0 into 2-3-too-old NZB × W male 
mice. 
:I: Serum levels of gp70  and haptoglobin were determined  1 d after injection 
and those of IgM, 5 d after. 
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Fro.  3.  The effect of colchicine on the serum gp70 response induced by 25 #g of LPS from E. co/i 
0111:B4.  The different doses of colchicine were  injected 3 h  after injection of LPS.  Each point 
represents  mean +  1 SD for five mice. O, LPS alone; A, LPS +  15 #g colehicine;  O, LPS +  100 #g 
colchicine;  r-I, 100 #g colchicine; &, saline. 
lymphocytes, we sought this glycoprotein's site of origin in the liver, a  major source of 
many  other  serum  proteins.  The  effect  of  colchicine,  an  inhibitor  of  the  plasma 
protein's  secretion  from the  liver, on  serum  gp70  responses  to  LPS was  examined  in 
NZB  ×  W  male  mice.  Inoculation  of 25/xg  LPS  followed  3  h  later  by  100/~g  of 
colchicine yielded greatly suppressed  rises in serum  levels of gp70 compared  to those 
induced  by LPS alone (Fig. 3).  12 h  after injection of LPS in colchicine-treated mice, 
serum  levels  of gp70  were  less  than  one  third  (133  ±  25  #g/ml)  of those  in  mice 
receiving  LPS  alone  (449  +  25  /~g/ml).  Less,  but  still  significant  suppression  was 
observed  in  mice injected with  15/~g colchicine  (215  -/- 47/~g/ml).  Colchicine alone 
did not significantly change baseline levels of gpT0 in serum. 352  SERUM  gp70  AS  AN  ACUTE  PHASE  REACTANT 
With  this experimental system, the  quantity  of gp70  in  various organs was then 
determined in NZB ×  W  female mice. The first group of mice were injected with 25 
#g LPS alone, the second with 25 pg LPS and 3 h later 100 #g of colchicine, the third 
with colchicine alone, and the fourth with saline alone (controls). gp70 was quanti- 
tated in livers, kidneys, spleens, thymuses, and lungs as well as in sera 9 h  after the 
injection  of LPS.  The amounts of gp70 recoverable in  liver extracts were 3.3  times 
higher  in  mice  receiving  LPS  alone  than  in  saline-injected  controls  (Table  V). 
However, other tissue extracts did not show this remarkable increase in the amounts 
of gp70. The subsequent injection of colchicine in LPS-treated mice further increased 
the  amounts  of gp70  in  their  livers,  but  not  in  any other  tissues  tested.  The  liver 
extracts from such mice contained 2.4 times as much gp70 as those from the animals 
injected with LPS alone, or 7.8 times as much as those from saline controls, in striking 
contrast to the blunted serum gp70 responses in colchicine-treated mice. Livers from 
animals treated with colchicine  alone contained  2.3  times higher concentrations  of 
gp70 than saline-injected controls. It was noteworthy that levels of gp70 in sera and 
livers  never  increased  after  injection  of LPS  administered  simultaneously  with  D- 
GalN, an inhibitor of protein synthesis (Table VI). 
To further identify the cellular origin of gp70,  livers from NZB ×  W  mice were 
analyzed  immunohistochemically.  Antiserum  specific  for  Rauscher  MuLV  gp70 
TABLE  V 
Accumulation of  gp70 in Livers from Mice Injected with LPS and Colchicine 
Treatment  Serum gp70* 
Tissue gp70* 
Liver  Kidney  Spleen  Thymus  Lung 
pg/ml  #g/organ 
LPS:[:  329±48  50±8  29±9  14+1  124-3  11±2 
LPS+Colchicine§  172:t:30  1184-23  334-5  164-1  134-2  114-2 
Colchicine  47 +  14  34 4- 5  28 4- 4  11  4-  l  10 4- 4  11  4- 2 
Saline  43 4- 8  15 4- 4  22 4- 5  14 4- 3  10 4-  1  9 4- 2 
* Amounts of gp70 in sera and in tissues were determined 9 h after the injection of LPS. Mean 4-  1 SD for 
seven mice. 
:~ 25 #g of LPS from E. coh" 01 t 1  :B4 was injected i,p.  into 2-mo-old NZB ×  W  female mice. 
§ 100 pg of eolchicine was injected i.p.  3 h after the injection of LPS. 
TABLE  VI 
Suppression of LPS-Induced gp 70 Response in Serum and Liver by n-GalN 
Treatment 
gp70* 
Serum  Liver 
~g/ml  t~g/organ 
LPS~  343.5  4- 55.8  66.9 ±  12.9 
LPS +  D-GaIN§  25.4 +  6.9  18.9 +  2.9 
D-GaIN  18.3 ±  1.6  16.5 ±  1.8 
Saline  36.4 +  7.5  20.2 +  3.3 
* Amounts of gp70 in sera and livers were determined 9 h  after injection of 
LPS. Mean 4-  1 SD for five mice. 
25/xg of LPS from E. coli  011 I:B4 was injected i.p.  into 2-mo-old NZB ×  W 
female mice. 
§ 7.5 mg of D-GalN was injected i.p. simultaneously with LPS. HARA,  IZUI,  AND  DIXON  353 
Fla.  4.  Demonstration ofgp70 in liver from NZB ×  W mice injected with LPS and colchicine by 
indirect  immunofluorescence using goat  anti-Rauscher  MuLV  gp70.  (A)  Liver specimen  from 
uninjected control mice. No specific  staining for gp70 is seen on these hepatocytes. (B) Section of 
liver from mice injected with LPS and colchicine. Colchicine (100 #g) was injected 3 h after the 
injection of LPS (25 #g) and liver was taken 9 h  after LPS injection. Granular staining indicates 
accumulation of gp70 in cytoplasm of hepatocytes. × 420. 
scarcely stained hepatocytes of untreated mice examined by indirect immunofluores- 
cence  (Fig.  4 A). However, livers of mice obtained 6  h  after administration of LPS 
began  to show a  fine granular staining of gp70  in most  hepatocytes and  in some 
sinusoidal margins, and at 9 h the distribution of gp70 was more extensive. Compared 
with mice injected with LPS alone, livers from mice receiving both LPS and colchicine 
showed more intense, coarse granular staining of gp70 in the cytoplasm of virtually 
all the hepatocytes without appreciable staining along the sinusoids (Fig. 4 B). Liver 
sections from mice treated with colchicine alone also had increased numbers of gp70- 
positive  hepatocytes,  After absorption  of antisera  to  Rauscher MuLV gp70  with 
Rauscher  MuLV,  no  positive staining appeared,  Liver sectiotls  from  BALB/c or 
C57BL/6 mice, which do not produce gp70 after injection of LPS (12),  showed no 
such specific staining, even after treatment with LPS and colchicine. 
Discussion 
Using an experimental  model  in which the expression of serum  gp70  is  greatly 
enhanced  after  the  injection  of LPS  (12),  we  have  demonstrated  that  this  gp70 
behaves  as  an  APR  and  is  mainly synthesized by  hepatic  cells.  Apparently,  this 
glycoprotein is significantly involved as an autoantigen in the pathogenesis of murine 
systemic lupus erythematosus (7,  17, 29-31). 
Lymphocytes have been suggested as the major source of serum gp70 (10). Indeed, 
lymphocytes express surface gp70 molecules with characteristics similar to serum gp70 
(10,  32),  and enhanced production of serum gp70  induced by LPS is seen only in 
murine strains whose thymocytes are positive for Cox  antigen  (12),  a  type-specific 
determinant  of the  gp70  molecule  (2,  9,  10,  33).  However, our results refute this 
possibility. First, T  cell-depleted mice produce  as  much serum  gp70  as  mice with 
normal numbers of T  cells after the injection of LPS, Second, the production of gp70 
is independent  of the activation of B cells, because lethal irradiation of mice preceding 
the injection of LPS completely abolishes the activation of B ceils, but has  no effect 354  SERUM gp70 AS AN ACUTE PHASE REACTANT 
on the serum gp70 response. Further, gp70 production is stimulated by such inducers 
of APR as turpentine oil or poly I-poly C without significant formation of polyclonal 
IgM antibodies.  Finally,  129(Gtx  +)  mice produce gp70 after stimulation with LPS, 
even after irradiation and  reconstitution with spleen cells from Gix- mice. To the 
contrary, 129(Gtx-) mice either unmanipulated or replenished with Gix  + spleen cells 
develop no serum gp70 responses. This experiment with radiation chimeras clearly 
indicates that the ability to generate a serum gp70 response is not dependent on the 
genotype of spleen cells, but rather related to that of nonlymphoid tissues. Of note, 
both chimeras developed equally high levels of polyclonal antibodies as a result of B 
cell activation. These results are consistent with a  previous report (11)  that  neither 
thymectomy, splenectomy, nor exchange of hematopoietic tissues between 129(GIx  +) 
and  129(Gtx-) mice affected levels of serum gp70 in either strain. All these findings 
exclude lymphoid cells as a major source of serum gp70. 
Instead,  our  results  strongly  suggest  the  liver as  the  major  site  of serum  gp70 
production. The experimental observations that  support  this conclusion are:  First, 
amounts of gp70 present in liver extracts of LPS-injected mice were more than three 
times higher than in uninjected controls, whereas no such increase appeared in other 
tissues  including  the  lung,  kidney,  spleen,  or  thymus.  Second,  the  injection  of 
colchicine, which is a  known inhibitor of protein release from hepatic cells (34, 35), 
greatly suppressed the serum gp70 response. Accordingly, increased amounts of gp70 
were  recoverable from  liver extracts  but  not  other  tissue  extracts,  indicating  the 
accumulation of newly synthesized gp70 in hepatic cells as colchicine inhibited its 
release. Third, o-GaiN, an inhibitor of protein synthesis (36, 37), completely prevented 
increase of gp70 in the liver or serum after the injection of LPS. Finally, immunohis- 
tochemical study more directly showed the presence of gp70 as fine granules in the 
cytoplasm of hepatic parenchymal cells from mice receiving LPS. Subsequent treat- 
ment  with  colchicine  intensified  this  specific  staining  by  gp70  in  almost  all  the 
hepatocytes. In all probability, hepatic cells are the major source of the gp70 that 
eventually enters the circulation. This conclusion is compatible with the fact that the 
concentration of gp70 in sera is generally 20-100% higher in male mice than females 
(11, 12, 17). The liver is a known source of  several proteins whose serum concentrations 
are associated markedly with the host's sex depending on androgenic hormones (38). 
A  particularly significant observation in this research is that serum gp70 behaves 
like an APR. Not only LPS but also other inducers of APR, such as turpentine oil or 
poly  I-poly  C  (39,  40),  enhanced  the  synthesis  of serum  gp70.  Notably,  neither 
turpentine oil nor poly I-poly C  activated B cells to produce polyclonal antibodies, 
ruling  out  possible  contamination  with  LPS  in  these  preparations.  Further,  the 
kinetics  of this  gp70  response were essentially  identical  to  those  of such  APR  as 
haptoglobin,  serum  amyloid A  protein,  or C-reactive protein  (26-28).  Finally, we 
recently demonstrated that  restriction of calorie intake in NZB  ×  W  mice reduced 
serum levels of the APR, haptoglobin, as well as gp70, but not that of albumin  (41). 
Consequently, serum gp70 has the qualities of an APR, and its expression is controlled 
by a mechanism similar to that for other APR. Hepatic cells undoubtedly synthesize 
gp70 and release it into the circulation as they do other APR (26, 28, 39, 42, 43). 
In view of (a)  the similarity in expression of serum gp70 and a  number of other 
proteins that are products of the host genome, (b) the failure of other retroviral gene 
(even env gene) products to be expressed along with serum gp70, and (c) the slight but HARA, IZUI, AND DIXON  355 
demonstrable  differences  between  serum  gp70  and  the  known  products  of  any 
retroviral env gene, it seems that this molecule behaves as a host gene product. 
Summary 
A single intraperitoneal injection of bacterial lipopolysaccharide (LPS) or its lipid 
A  component induced  high levels of glycoprotein, gp70, in sera of several strains of 
mice within 24 h. This serum gp70 response induced by LPS was independent of the 
activation of B cells and the presence of T  cells. However, serological and immuno- 
histochemical studies demonstrated the production of gp70 by hepatic parenchymal 
ceils and its subsequent release into the circulating blood. 
The expression of gp70 in the serum was enhanced not only by LPS but also other 
inducers  of acute phase reactants  (APR)  such as turpentine oil or polyriboinosinic- 
polyribocytidylic acid. Further, the serum gp70 response was kinetically identical to 
those of APR. These results strongly suggest that (a) the liver may be the major source 
for  serum  gp70,  (b)  serum  gp70  behaves  like  an  APR,  (c)  its  expression  may be 
controlled by a  mechanism similar to that  for other APR, and  (at) this glycoprotein 
apparently behaves as a normal host constituent and not a product of a viral genome. 
We thank Dr. John H. Elder for his valuable suggestion  and discussion  during the course of 
investigation.  The excellent  technical  assistance  of Mr.  Cary Lindstrom  and  the  excellent 
secretarial and editorial assistance  of Mr. Kieth L. Dunn, Ms. Nancy Hoffer, and Ms. Phyllis 
Minick are gratefully acknowledged. 
Received  for publication 21 September 1981. 
References 
1.  August, J. T., D. P.  Bolognesi, E. Fleissner,  R. V. Gilden, and R. C. Nowinski.  1974. A 
proposed nomenclature for the virion proteins of oncogenic RNA viruses.  Virology. 60"595. 
2.  Lerner, R. A., C. B. Wilson,  B. C. Del Villano, P. J. McConahey, and F. J. Dixon.  1976. 
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, 
and physiologic studies of the major viral glycoprotein, gp70.J. Exp. Med.  143:151. 
3.  Hino, S., J. R. Stephenson, and S. A. Aaronson.  1976. Radioimmunoassays for the 70,000- 
molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expres- 
sion in normal mouse tissues and sera.J.  Virol. 18:933. 
4.  Strand, M., and J. T. August.  1976. Oncornavirus envelope glycoprotein in serum of mice. 
Virology. 75:130. 
5.  Elder, J. H., F. C. Jensen, M. L. Bryant, and R. A. Lerner.  1977. Polymorphism of the 
major envelope of glycoprotein  (gp70)  of murine C-type viruses:  virion associated and 
differential antigens encoded by a muiti-gene family. Nature (Lond.). 267:23. 
6.  Elder, J. H., J. W. Gautsch, F. C. Jensen, R. A. Lerner, T. M. Chused, H. C. Morse, J. W. 
Hartley, and W. P. Rowe.  1980. Differential expression  of two distinct xenotropic viruses 
in NZB mice. Clin. lmraunol, lmmunopathol. 15:493. 
7.  Izui, S., J. H. Elder, P. J. McConahey, and F. J. Dixon.  1981. Identification of retroviral 
gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZB × NZW 
mice.J. Exp. Med. 153:1151. 
8.  Del Villano,  B.  C.,  B.  Nave, B.  P.  Croker, R.  A.  Lerner, and  F. J.  Dixon.  1975. The 
oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant 
thymocytes.J. Exp. Med. 141:172. 
9.  Tung, J.-S., E. S. Vitetta, E. Fleissner, and E. A. Boyse. 1975. Biochemical evidence linking 356  SERUM gp70 AS AN ACUTE PHASE REACTANT 
the  C,  xx  thymocyte surface  antigen  to  the  gp69/71  envelope  glycoprotein  of murine 
leukemia virus.J. Exp. Med. 141:198. 
10.  Obata,  Y.,  H.  Ikeda,  E.  Stockert,  and  E.  A.  Boyse.  1975. Relation  of C,  rx  antigen  of 
thymocytes of envelope glycoprotein of murine leukemia virus.J. Exp. Med. 141:188. 
11.  Obata,  Y.,  E.  Stockert,  M.  Yamaguchi,  and  E.  A.  Boyse.  1978. Source and  hormone- 
dependence of Gtx-gp70 in mouse serum.J.  Exp. Med. 148:793. 
12.  Hara,  I., S.  Izui,  P. J.  MeConahey, J.  H.  Elder,  F.  C. Jensen,  and  F. J.  Dixon.  1981. 
Induction of high serum levels of retroviral env gene products (gp70)  in mice by bacterial 
lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 78:4397. 
13.  Westphal, O., and K. Jann.  1965. Bacterial lipopolysaccharides. Extraction with phenol- 
water and further applications of the procedure. Methods Carbohydr. Chem. 5:83. 
14.  Morrison,  D.  C., and  L. Leive.  1975. Isolation and characterization  of two fractions of 
lipopolysaeeharide from E. coli 0111:B4.J. Biol. Chem. 250,2911. 
15.  Anaeker, R. L., W. D. Bickel, W. T. Haskins, K. C. Milner, E. Ribi, and J. A. Rudbach. 
1966. Frequency of occurrence of native hapten among enterobacterial species. J. Bacteriol. 
91:1427. 
16.  Nieva, M., C. Milner, E. Ribi, and J. A. Rudhaeh.  1969. Alteration in physical, chemical 
and biological properties of endotoxin by treatment with mild alkali.J.  Bacteriol. 97:1069. 
17.  Izui, S.,  P. J.  McConahey, A. N. Theofilopoulos, and F. J.  Dixon.  1979. Association of 
circulating  retroviral  gp70-anti-gp70  immune  complexes  with  murine  systemic  lupus 
erythematosus.J. Exp. Med. 149.1099~ 
18.  Izui, S., R. A. Eisenberg, and F. J. Dixon.  1979. IgM rheumatoid factors in mice injected 
with bacterial lipopolysaccharides.J. Immunol. 122:2096. 
19.  Izui, S., D. C. Morrison, B. Curry and F. J. Dixon. 1980. Effect of lipid A-associated protein 
and  lipid  A  on the expression of lipopolysaceharide activity. I.  Immunological activity. 
Immunology. 40:473. 
20.  Mancini,  G.,  A. Carbonara,  and J.  Heremans.  1965. Immunoehemieal  quantitation  of 
antigens by single radial immunodiffusion. Immunochemist~y. 2:235. 
21.  Mathison, J. C., and R. J. Uleviteh.  1979. The clearance, tissue distribution, and cellular 
localization of intravenously injected lipopolysaeeharide in rabbits.J.  Immunol. 123:2133. 
22.  McLean, I. W., and P.  K.  Nakane.  1974. Periodate-lysine-paraformaldehyde fixative.  A 
new fixative for immunoelectron microseopy.J. Histochem. Cytochem. 22:1077. 
23.  Coutinho, A., and G. M611er. 1975. Thymus-independent B cell induction and paralysis. 
Adv. Immunol. 21:113. 
24.  Wecker, E., A. Sehimpl, and T.  Hunig.  1977. Expression of MuLV gp70-1ike antigen in 
normal mouse spleen cells induced by antigenic stimulation. Nature (Lond.). 269.598. 
25.  Moroni,  C.,  and  G.  Schumann.  1977. Are  endogenous C-type viruses  involved  in  the 
immune system; Nature (Lond.). 269.600. 
26.  Koj, A. 1974. Acute-phase reactants. In: Structure and Function of Plasma Proteins. Ed., 
A. C. Allison.  Plenum Publishing Corp. New York. 1:73. 
27.  Yen-Watson, B., and I. Kushner.'1974. Rabbit CRP response to endotoxin administration: 
dose-response relationship and kinetics.  Proc. Soc. Exp. Biol. Med. 146:1132. 
28.  MeAdam,  K.  P.  W.  J.,  and  J.  D.  Sipe.  1976. Murine  model  for  human  secondary 
amyloidosis: genetic variability of the acute-phase serum protein SAA response to endo- 
toxins and easein.J. Exp. Med. 144:1121. 
29.  Yoshiki,  T.,  R.  C.  Mellors,  M.  Strand,  and  J.  T.  August.  1974. The  viral  envelope 
glycoprotein of murine leukemia virus and pathogenesis of immune complex glomerulo- 
nephritis of New Zealand mice.J. Exp. Med. 140:1011. 
30.  Izui, S., V. E. Kelley, P. J.  McConahey, and F. J.  Dixon.  1980. Selective suppression of 
retroviral  gp70-anti-gp70  immune  complex  formation  by  prostaglandin  Ex  in  murine 
systemic lupus erythematosus.J. Exp. Med. 152:1645. HARA, IZUI, AND DIXON  357 
31.  Izui, S.,  P. J.  McConahey, J.  P.  Clark,  L.  M.  Hang,  I.  Hara,  and  F. J.  Dixon.  1981. 
RetroviraJ gp70 immune complexes in NZB X NZW F2 mice with murine lupus nephritis. 
J. Exp. Med. 154:517. 
32.  Morse, H. C., III, T. M. Chused, M. Boehm-Truitt, B. J. Mathieson, S. O. Sharrow, and 
J.  W.  Hartley.  1979. XenCSA: cell  surface antigens  related  to the major glycoproteins 
(gp70) of xenotropic murine leukemia viruses.,/7. Immunol. 123:443. 
33.  Stockert, E., L. J. Old, and E. A. Boyse.  1971. The Cnx system. A cell surface alloantigen 
associated with murine leukemia virus; implications regarding chromosomal integration of 
the viral genome.J. Exp. Med. 133:1334. 
34.  Stein, O., and Y. Stein. 1973. Colchicine-indueed inhibition of very low density lipoprotein 
release  by rat liver in vivo. Biochim. Biophys. Acta. 306:142. 
35.  Redman, C. M., D. Banerjee, K. Howell, and G. E. Palade.  1975. Coichicine inhibition of 
plasma protein release  from rat hepatocytes.J. Cell. Biol. 66:42. 
36.  Anukarahanonta, T., H. Shinozuka, and E. Farber.  1973. Inhibition of protein synthesis in 
rat liver by D-galactosamine. Res. Com. Chem. Pathol. Pharmacol. 5:481. 
37.  Sipe, J. D.  1978. Induction of the acute-phase serum protein SAA requires both RNA and 
protein synthesis.  Br. J. Exp. Pathol. 59:305. 
38.  Gustaffson, J. A., P. Eneroth, A. Pousette, P. Skett, C. Sonnenschein, A. Stenberg, and A. 
Ahl~n.  1977. Programming and  differentiation  of rat  liver  enzymes. J.  Steroid Biochem. 
8:429. 
39.  Courtoy, P. J., C. Lombart, G. Feldmann, N. Moguilevsky, and E. Rogier. 1981. Synchro- 
nous increase of four acute phase proteins synthesized by the same hepatocytes during the 
inflammatory reaction. A combined biochemical and morphologic kinetics study in the rat. 
Lab. Invest. 44:105. 
40.  McAdam,  K.  P.  W. J.,  and J.  L.  Ryan.  1978. C57BL/10/CR  mice:  nonresponders  to 
activation by the lipid A moiety of bacterial lipopolysaccharide. J. Immunol. 120:.249. 
41.  Izui, S.,  G. Fernandes,  I. Hara, P. J.  McConahey, F.  C. Jensen,  F. J.  Dixon, and R. A. 
Good. 1981. Low-calorie diet selectively reduces expression of retroviral envelope glycopro- 
tein gp70 in sera ofNZB ×  NZW F1 hybrid mice.J. Exp. Med. 154:1116. 
42.  Neuhaus, O. W., and A. Liu.  1964. Biochemical significance of serum glycoproteins. III. 
Hepatic production ofal and a2 globulins responding to injury. Proc. Soc. Exp. Biol. Med. 
117:244. 
43.  Alper, C. A., D. Raum, Z. L. Awdeh, B. H. Petersen, P. D. Taylor, and T. E. Starzl.  1980. 
Studies of hepatic synthesis in vivo of plasma proteins, including orosomucoid, transferrin, 
al-antitrypsin, C8, and factor B. Clin. Immunol. Immunopathol. 16:84. 